JP Morgan Chase’s Hinge Health HNGE Stock Holding History

JP Morgan Chase’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,400	Closed	-$65K	–	8044
2025 Q4	$65K	Buy	+1,400	New	+$67.4K	﹤0.01%	6111

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase's HNGE Position: Q2 2026 in Review

JP Morgan Chase reduced its Hinge Health (HNGE) stake by 11% in Q2 2026, selling an estimated $4.68M and leaving 718,176 shares worth $58.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

JP Morgan Chase first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

JP Morgan Chase held 718,176 shares of Hinge Health worth $58.7M as of Q2 2026.
JP Morgan Chase sold 86,255 Hinge Health shares in Q2 2026, an estimated $4.68M.
Hinge Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1362 holding.
JP Morgan Chase first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.